JP2019517576A5 - - Google Patents

Download PDF

Info

Publication number
JP2019517576A5
JP2019517576A5 JP2019514190A JP2019514190A JP2019517576A5 JP 2019517576 A5 JP2019517576 A5 JP 2019517576A5 JP 2019514190 A JP2019514190 A JP 2019514190A JP 2019514190 A JP2019514190 A JP 2019514190A JP 2019517576 A5 JP2019517576 A5 JP 2019517576A5
Authority
JP
Japan
Prior art keywords
excipient
beta
mixed
liquid formulation
hydroxyisovaleric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019514190A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019517576A (ja
JP6929939B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/034551 external-priority patent/WO2017205673A1/en
Publication of JP2019517576A publication Critical patent/JP2019517576A/ja
Publication of JP2019517576A5 publication Critical patent/JP2019517576A5/ja
Application granted granted Critical
Publication of JP6929939B2 publication Critical patent/JP6929939B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019514190A 2016-05-25 2017-05-25 ソフトゲルカプセルにおけるベータ−ヒドロキシイソ吉草酸製剤の安定化 Active JP6929939B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662341464P 2016-05-25 2016-05-25
US62/341,464 2016-05-25
PCT/US2017/034551 WO2017205673A1 (en) 2016-05-25 2017-05-25 Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules

Publications (3)

Publication Number Publication Date
JP2019517576A JP2019517576A (ja) 2019-06-24
JP2019517576A5 true JP2019517576A5 (enExample) 2020-06-11
JP6929939B2 JP6929939B2 (ja) 2021-09-01

Family

ID=60411620

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019514190A Active JP6929939B2 (ja) 2016-05-25 2017-05-25 ソフトゲルカプセルにおけるベータ−ヒドロキシイソ吉草酸製剤の安定化

Country Status (12)

Country Link
US (3) US10959957B2 (enExample)
EP (1) EP3463327B1 (enExample)
JP (1) JP6929939B2 (enExample)
KR (1) KR102384266B1 (enExample)
CN (2) CN121177244A (enExample)
AU (1) AU2017270219B2 (enExample)
CA (1) CA3024584A1 (enExample)
CO (1) CO2018014085A2 (enExample)
MX (1) MX2018014407A (enExample)
MY (1) MY199597A (enExample)
RU (1) RU2018145520A (enExample)
WO (1) WO2017205673A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111888325A (zh) * 2020-08-04 2020-11-06 瑞希(重庆)生物科技有限公司 一种卡拉胶凝胶、药物赋形剂和皮肤外用制剂
JP7750505B2 (ja) * 2021-10-14 2025-10-07 中日本カプセル 株式会社 カプセル及びカプセルの製造方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870062A (en) * 1956-04-27 1959-01-20 Scherer Corp R P Gelatin composition for capsules
US5200191A (en) 1991-09-11 1993-04-06 Banner Gelatin Products Corp. Softgel manufacturing process
US5569466A (en) 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US6340473B1 (en) 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
DE10064312C2 (de) 2000-12-22 2003-05-22 Degussa Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
US7740878B2 (en) * 2001-10-22 2010-06-22 Danisco A/S Use of betaine to enhance exercise performance
ATE374602T1 (de) 2001-12-21 2007-10-15 Supernus Pharmaceuticals Inc Orale kapselformulierung mit verbesserter physikalischer stabilität
DE10208568A1 (de) 2002-02-27 2003-09-18 Degussa Bioactives Deutschland Verbindung, enthaltend Kreatin, eine Säure-Komponente und/oder einen Komplex-Bildner
DE10217557A1 (de) 2002-04-19 2003-11-06 Degussa Bioactives Gmbh Funktionsnahrungsmittel enthaltend eine Phospholipid-haltige stabile Matrix
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US8231896B2 (en) * 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
DE102004060914A1 (de) 2004-12-17 2006-07-06 Bioghurt Biogarde Gmbh & Co. Kg Verwendung von Liponsäure-haltigen Cyclodextrin-Komplexen
EP2242489A1 (en) * 2005-02-15 2010-10-27 Jallal Messadek Combination therapeutic compositions and method of use
DE102005061765A1 (de) 2005-05-19 2006-11-23 Degussa FreshTech Beverages LLC, Milwaukee Füllmaterial für einen Getränkebehälter
CN101574146B (zh) * 2008-05-07 2012-06-13 北京康比特体育科技股份有限公司 一种含有hmb的运动营养补剂
JP2009153529A (ja) * 2009-04-17 2009-07-16 Tsujido Chemical Corp 食品組成物
ES2608483T3 (es) * 2009-12-18 2017-04-11 Metabolic Technologies, Inc. Método mejorado de administración de beta-hidroxi-beta-metilbutirato (HMB)
CN103338658A (zh) 2010-12-22 2013-10-02 雅培制药有限公司 含有β-羟基-β甲基丁酸钙和共轭亚油酸的营养型产品
MX2014000419A (es) * 2011-07-15 2014-09-22 Nusirt Sciences Inc Composicones y metodos para modular trayectorias metabolicas.
BR112015005199B1 (pt) 2012-09-10 2022-09-06 Metabolic Technologies, Inc Composição, e, método para fornecer um benefício a um animal em necessidade do mesmo
BR112015010947A2 (en) 2012-11-13 2018-06-05 Nusirt Sciences, Inc. compositions and methods for increasing energy metabolism.
US20140272000A1 (en) 2013-03-14 2014-09-18 Metabolic Technologies, Inc. Liquids and Foodstuffs Containing beta-hydroxy-beta-methylbutyrate (HMB) in the Free Acid Form and Methods of Manufacturing or Producing the Same
JP6389237B2 (ja) * 2013-03-15 2018-09-12 パセオン ソフトジェルズ インコーポレイティド 非ゼラチン性腸溶性軟質カプセル
HK1221609A1 (zh) 2013-05-01 2017-06-09 Abbott Laboratories 增强老化肌肉再生的方法
EP3082778B1 (en) * 2013-12-18 2019-04-03 Capsugel Belgium NV Stable liquid filled hard capsule comprising beta-hydroxy-beta-methylbutyric acid
WO2015195990A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Liquid-filled immediate release soft gelatin capsules
JP2018090504A (ja) * 2016-11-30 2018-06-14 株式会社東洋新薬 筋肉増強用組成物

Similar Documents

Publication Publication Date Title
Riehl et al. The 2-category theory of quasi-categories
Parker Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea
JP2010510212A5 (enExample)
CO2017002472A2 (es) Formulación de acetato de abiraterona
HK1247856A1 (zh) 羟丙基β-环糊精组合物及方法
MY174434A (en) Method of manufacturing enteric seamless soft capsule
WO2012174379A3 (en) Polyhedral cage-containing metalloporphyrin frameworks, methods of making, and methods of using
EP4279137A3 (en) Oral pharmaceutical composition and method for producing particulate formulation comprising composition
Mironov et al. Racah matrices and hidden integrability in evolution of knots
HK1220445A1 (zh) 具有摇溶性以及增强的溶解再现性和稳定性的组合物
WO2018084627A3 (en) Pharmaceutical complex formulation comprising amlodipine, losartan and chlorthalidone
JP2016000763A5 (enExample)
JP2016014060A5 (enExample)
Li et al. Distorted mix method for constructing copulas with tail dependence
WO2015140748A3 (en) Sildenafil solutions and methods of making and using same
EP3354283A3 (en) Pharmaceutical capsule composition comprising silodosin
WO2016009400A3 (en) An improved thermostable spray dried rotavirus vaccine formulation and process thereof
JP2018042821A5 (enExample)
WO2016130786A3 (en) Flaviviridae proteins and virions and methods of use thereof
PH12014502170B1 (en) Drug composition and soft capsule drug sealing the drug composition
WO2016133333A3 (en) An oral pharmaceutical formulation comprising sustained-release granules containing tamsulosin hydrochloride
MY175693A (en) A method to produce slow release delivery carrier lipid nanoparticles of different log p value
BR112017003135A2 (pt) partículas de gelatina/pectina
Aluja et al. Correction to: Development of the Zuckerman–Kuhlman–Aluja Personality Questionnaire (ZKA–PQ): A Factor/Facet Version of the Zuckerman–Kuhlman Personality Questionnaire (ZKPQ)
Wei et al. Opening-up Policy of China under New Circumstances: Objectives, Challenges and Development Trends